Dalton Launches Clinical Injectables Service
Dalton Pharma Services announced on Dec. 2, 2014 that it will launch “Steriles Made Simple” programs designed to produce clinical sterile liquid injectables faster. Dalton will use pre-prepared material, process, and systems to deliver cGMP sterile liquid injectables to customers within four months of available APIs, specifically small molecule Phase I/II projects requiring batches of 10,000 vials or less.
“We looked at the critical aspects of cGMP sterile vial manufacturing that resulted in the longest timelines and really simplified this complex process for our customers. Steriles Made Simple (SM) has been a strategic priority for Dalton with a focus on delivering product faster, without compromising the quality,” said Peter Pekos, CEO & president of Dalton Pharma Services, in a press release.
Source: Dalton Pharma Services
Drug Solutions Podcast: Gliding Through the Ins and Outs of the Pharma Supply Chain
November 14th 2023In this episode of the Drug Solutions podcast, Jill Murphy, former editor, speaks with Bourji Mourad, partnership director at ThermoSafe, about the supply chain in the pharmaceutical industry, specifically related to packaging, pharma air freight, and the pressure on suppliers with post-COVID-19 changes on delivery.
Drug Solutions Podcast: Emerging Methods of Vaccine Administration and Distribution
June 20th 2023Michael Schrader, CEO and co-founder of Vaxess, discusses the latest on vaccine administration and different ways the pharmaceutical industry can distribute these products with Pharmaceutical Technology editor Jill Murphy.
